Nous contacter
Entete logo Orgametrie Accueil

Publications

Nous sommes auteurs et co-auteurs de nombreuses publications dans des revues médicales et scientifiques à comité de lecture, consultables en ligne sur notre site.


Recherche
Afficher les publications par défaut
Afficher les publications pour l'année :
Afficher les publications du thème :

070

Clin Rheumatol. 2014 Feb 2.

Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab.
Heusele M, Clerson P, Guery B, Lambert M, Launay D, Lefevre G, Morell-Dubois S, Maillard H, Le Gouellec N, Hatron PY, Hachulla E.

test

069

Ann Rheum Dis. 2013 Oct 9. doi: 10.1136/annrheumdis-2013-203779. [Epub ahead of print]

Revisiting comorbidities in gout: a cluster analysis.
Richette P, Clerson P, Périssin L, Flipo RM, Bardin T.

test

068

Ann Rheum Dis. 2013 Dec 1;72(12):1940-6. doi: 10.1136/annrheumdis-2012-202489. Epub 2012 Nov 24.

Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era.

Launay D, Sitbon O, Hachulla E, Mouthon L, Gressin V, Rottat L, Clerson P, Cordier JF, Simonneau G, Humbert M.

test

067

Arch Cardiovasc Dis. 2012 Jun-Jul;105(6-7):355-65. Epub 2012 Jun 28.

Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.

Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut JF, Genoun M; French National College of Cardiologists.

test

066

Crit Care. 2012 Oct 4;16(5):R185. [Epub ahead of print]

Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice.

Desmettre T, Dehours E, Samama CM, Jhundoo S, Pujeau F, Guillaudin C, Hecquart C, Clerson P, Crave JC, Jaussaud R.

test

065

Therapeutic Advances in Neurological Disorders, July 2012; vol. 5, 4: pp. 187-198.

Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation

Charles Pierrot-Deseilligny, Sophie Rivaud-Péchoux, Pierre Clerson, Raphaël de Paz ,Jean-Claude Souberbielle

test

064

Arthritis Rheum. 2012 Jan 31. doi: 10.1002/art.34408.

Could the "Cochin risk prediction score" be applied in daily practice to predict pulmonary hypertension in systemic sclerosis?

Hachulla E, Clerson P, Humbert M.

test

063

Arthritis Rheum. 2011 Nov;63(11):3522-30. doi: 10.1002/art.30541.

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival.

Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D, Gressin V, Guillevin L, Clerson P, Simonneau G, Hachulla E.

test

062

N Engl J Med. 2011 Jul 7;365(1):44-53.

A hemodynamic study of pulmonary hypertension in sickle cell disease.

Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, Habibi A, Bennani S, Savale L, Adnot S, Maitre B, Yaïci A, Hajji L, O'Callaghan DS, Clerson P, Girot R, Galacteros F, Simonneau G.

test

061

Chest. 2011 Apr 7. [Epub ahead of print]

Clinical characteristics and survival in systemic sclerosis-related PH associated With ILD.

Launay D, Humbert M, Berezne A, Cottin V, Allanore Y, Couderc LJ, Bletry O, Yaici A, Hatron PY, Mouthon L, Le Pavec J, Clerson P, Hachulla E.

test

1 2 3 4 5 6 7 8